Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 0.14 million during the last session, with the company’s beta value hitting 1.02. At the close of trading, the stock’s price was $1.61, to imply an increase of 0.62% or $0.01 in intraday trading. The QNCX share’s 52-week high remains $2.45, putting it -52.17% down since that peak but still an impressive 68.32% since price per share fell to its 52-week low of $0.51. The company has a valuation of $73.20M, with an average of 0.28 million shares in intraday trading volume over the past 10 days and average of 361.30K shares over the past 3 months.
Quince Therapeutics Inc (NASDAQ:QNCX) trade information
After registering a 0.62% upside in the last session, Quince Therapeutics Inc (QNCX) has traded red over the past five days. The 5-day price performance for the stock is 7.33%, and 53.33% over 30 days. With these gigs, the year-to-date price performance is 122.07%. Short interest in Quince Therapeutics Inc (NASDAQ:QNCX) saw shorts transact 0.47 million shares and set a 1.57 days time to cover.
Quince Therapeutics Inc (QNCX) estimates and forecasts
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 7.53% for the past 5-year period. While 2025 is set for a 25.95% return in earnings, projections for the next 5 years are at 25.46% annually.
QNCX Dividends
Quince Therapeutics Inc has its next earnings report out on 2025-May-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Quince Therapeutics Inc (NASDAQ:QNCX)’s Major holders
Quince Therapeutics Inc insiders hold 13.14% of total outstanding shares, with institutional holders owning 22.25% of the shares at 25.62% float percentage. In total, 22.25% institutions holds shares in the company.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Quince Therapeutics Inc (QNCX) shares. Going by data provided on Mar 31, 2025, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 861.39 shares. This is just over 1.89% of the total shares, with a market valuation of $1.39 million. Data from the same date shows that the other fund manager holds a little less at 418.22, or 0.92% of the shares, all valued at about 0.67 million.
